ES2120052T3 - Receptor de prostaglandina fp y dna que lo codifica. - Google Patents

Receptor de prostaglandina fp y dna que lo codifica.

Info

Publication number
ES2120052T3
ES2120052T3 ES94918699T ES94918699T ES2120052T3 ES 2120052 T3 ES2120052 T3 ES 2120052T3 ES 94918699 T ES94918699 T ES 94918699T ES 94918699 T ES94918699 T ES 94918699T ES 2120052 T3 ES2120052 T3 ES 2120052T3
Authority
ES
Spain
Prior art keywords
receptor
dna
prostaglandina
codes
host cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918699T
Other languages
English (en)
Inventor
Mark Abramovitz
Richard Grygorczyk
Kathleen Metters
Truyen Nguyen
Thomas H Rushmore
Deborah Slipetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of ES2120052T3 publication Critical patent/ES2120052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN RECEPTOR DE PROSTAGLANDINA NOVEDOSO QUE HA SIDO IDENTIFACADO Y DNA QUE LO CODIFICA Y QUE HA SIDO AISLADO, PURIFICADO Y SECUENCIADO Y EXPRESADO EN CELULAS ANFITRIONAS. EL DNA QUE CODIFICA AL RECEPTOR NOVEDOSO Y LAS CELULAS ANFITRIONAS QUE LO EXPRESAN SE UTILZIAN PARA IDENTIFICAR MODULADORES DEL RECPTOR DE PROSTAGLANDINA.
ES94918699T 1993-06-25 1994-06-09 Receptor de prostaglandina fp y dna que lo codifica. Expired - Lifetime ES2120052T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/083,741 US5869281A (en) 1993-06-25 1993-06-25 DNA encoding prostaglandin receptor FP

Publications (1)

Publication Number Publication Date
ES2120052T3 true ES2120052T3 (es) 1998-10-16

Family

ID=22180389

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918699T Expired - Lifetime ES2120052T3 (es) 1993-06-25 1994-06-09 Receptor de prostaglandina fp y dna que lo codifica.

Country Status (9)

Country Link
US (3) US5869281A (es)
EP (1) EP0705276B1 (es)
JP (1) JP3228751B2 (es)
AT (1) ATE170532T1 (es)
AU (1) AU6991894A (es)
CA (1) CA2165954C (es)
DE (1) DE69413039T2 (es)
ES (1) ES2120052T3 (es)
WO (1) WO1995000551A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202892D0 (sv) 1992-10-02 1992-10-02 Kabi Pharmacia Ab Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
US6670134B1 (en) 1993-11-19 2003-12-30 Allergan, Inc. Human EP3 prostaglandin receptor
US6057433A (en) 1993-11-19 2000-05-02 Allergan Sales, Inc. Nucleic acid encoding human EP3 prostaglandin receptor
US7294331B2 (en) 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
EP0812353A2 (en) 1995-01-26 1997-12-17 Merck Frosst Canada Inc. Prostaglandin receptor dp
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor
JP4431280B2 (ja) 1998-09-17 2010-03-10 オピタル・サント−ジュスティーヌ Ｇタンパク質共役型受容体アゴニストまたはアンタゴニスト
US6984719B1 (en) 1998-09-17 2006-01-10 Hospital Sainte-Justine Peptide antagonists of prostaglandin F2α receptor
WO2000029614A1 (en) * 1998-11-12 2000-05-25 Gemini Genomics Ab. Human prostaglandin receptors and methods of use thereof
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
CA2396739A1 (en) 1999-12-06 2001-06-14 Krishna G. Peri Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
DE60236951D1 (de) * 2001-05-21 2010-08-19 Fujifilm Corp Vorrichtung zur Durchführung biochemischer Analysen und Verfahren zu ihrer Herstellung
US7521530B2 (en) 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
WO2004073590A2 (en) * 2003-02-24 2004-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha)
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same
US20050074847A1 (en) * 2003-10-07 2005-04-07 Yanbin Liang Human prostaglandin EP1 receptor variants and methods of using same
US20050084929A1 (en) * 2003-10-17 2005-04-21 Yanbin Liang Human prostaglandin EP4 receptor variants and methods of using same
US20050084931A1 (en) * 2003-10-20 2005-04-21 Yanbin Liang Human prostaglandin DP receptor variants and methods of using same
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202892D0 (sv) * 1992-10-02 1992-10-02 Kabi Pharmacia Ab Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof

Also Published As

Publication number Publication date
EP0705276A1 (en) 1996-04-10
CA2165954A1 (en) 1995-01-05
WO1995000551A1 (en) 1995-01-05
JP3228751B2 (ja) 2001-11-12
US5840847A (en) 1998-11-24
EP0705276B1 (en) 1998-09-02
US5869281A (en) 1999-02-09
JPH11505701A (ja) 1999-05-25
US6358694B1 (en) 2002-03-19
AU6991894A (en) 1995-01-17
CA2165954C (en) 2005-04-26
ATE170532T1 (de) 1998-09-15
DE69413039D1 (de) 1998-10-08
DE69413039T2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
FR2710063B1 (fr) 3-Aryl-benzofurannones, utilisées en tant que stabilisants, compositions les contenant, et leur utilisation.
SE9301270D0 (sv) Biosensor
DE69014440D1 (de) Sprachcodierungs-/-decodierungssystem.
FI965201A0 (fi) Puhdistetut Polyporus-lakkaasit ja niitä koodaavat nukleiinihapot
MX9403899A (es) Adn que codifica al receptor ep1 de prostaglandina
ATE196651T1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ATE415480T1 (de) B7l-1 moleküle
CA2211204A1 (en) Prostaglandin receptor dp
ES2122291T3 (es) Receptor ep3 de la prostaglandina y adn que lo codifica.
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
ATE294862T1 (de) Humane sel-10 polypeptiden und dafur kodierende polynukleotiden
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
NO905545D0 (no) Renset ubiquitinhydrolase, dna-sekvenser som koder for samme, samt anvendelse for isolering av polypeptider.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 705276

Country of ref document: ES